James Stillman  Hanson net worth and biography

James Hanson Biography and Net Worth

General Counsel of Fortrea

J. Stillman Hanson is General Counsel and has served in this position since Fortrea’s launch as an independent company in July 2023.

Stillman has more than two decades of legal experience in both private practice and in-house positions, serving as strategic business advisor and partner as well as counsel on legal, compliance and corporate governance matters. Prior to joining Labcorp, he served as General Counsel, Chief Compliance Officer and Corporate Secretary at G1 Therapeutics, Inc., a publicly traded biopharmaceutical company from 2018 to 2023. Before that, Stillman was Associate General Counsel and Vice President at IQVIA, a publicly traded healthcare services company from 2016 to 2018. Stillman served as Associate General Counsel at Quintiles from 2010 to 2016, where he participated in Quintiles’ initial public offering in 2013 and contributed to Quintiles merger with IMS Health to create QuintilesIMS in 2016. Prior to joining Quintiles, he practiced corporate and securities law at Smith, Anderson, Blount, Dorsett, Mitchell & Jernigan, LLP, a Raleigh, North Carolina law firm. 

Stillman earned his JD from the University of North Carolina School of Law and a bachelor's degree in Economics and History from Wake Forest University. He is admitted to the North Carolina State Bar.

What is James Stillman Hanson's net worth?

The estimated net worth of James Stillman Hanson is at least $268.43 thousand as of September 9th, 2025. Mr. Hanson owns 19,092 shares of Fortrea stock worth more than $268,434 as of December 4th. This net worth approximation does not reflect any other assets that Mr. Hanson may own. Learn More about James Stillman Hanson's net worth.

How do I contact James Stillman Hanson?

The corporate mailing address for Mr. Hanson and other Fortrea executives is 8 Moore Drive, Durham, NC 27709, United States, . Fortrea can also be reached via phone at 877-495-0816 and via email at [email protected]. Learn More on James Stillman Hanson's contact information.

Has James Stillman Hanson been buying or selling shares of Fortrea?

James Stillman Hanson has not been actively trading shares of Fortrea during the last quarter. Most recently, James S. Hanson sold 1,677 shares of the business's stock in a transaction on Tuesday, September 9th. The shares were sold at an average price of $10.23, for a transaction totalling $17,155.71. Following the completion of the sale, the general counsel now directly owns 19,092 shares of the company's stock, valued at $195,311.16. Learn More on James Stillman Hanson's trading history.

Who are Fortrea's active insiders?

Fortrea's insider roster includes James Hanson (General Counsel), Jill McConnell (CFO), Peter Neupert (Director), and Thomas Pike (CEO & Chairman). Learn More on Fortrea's active insiders.

Are insiders buying or selling shares of Fortrea?

In the last twelve months, Fortrea insiders bought shares 3 times. They purchased a total of 72,354 shares worth more than $507,168.10. In the last twelve months, insiders at the sold shares 10 times. They sold a total of 28,661 shares worth more than $342,991.24. The most recent insider tranaction occured on September, 9th when CAO Robert Parks sold 592 shares worth more than $6,056.16. Insiders at Fortrea own 0.4% of the company. Learn More about insider trades at Fortrea.

Information on this page was last updated on 9/9/2025.

James Stillman Hanson Insider Trading History at Fortrea

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/9/2025Sell1,677$10.23$17,155.7119,092View SEC Filing Icon  
6/3/2025Sell2,191$4.17$9,136.4714,981View SEC Filing Icon  
6/12/2024Buy2,000$25.30$50,600.007,475View SEC Filing Icon  
See Full Table

James Stillman Hanson Buying and Selling Activity at Fortrea

This chart shows James S Hanson's buying and selling at Fortrea by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Fortrea Company Overview

Fortrea logo
Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. The company operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services, as well as consulting services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Read More

Today's Range

Now: $14.50
Low: $13.06
High: $14.52

50 Day Range

MA: $10.68
Low: $8.40
High: $14.58

2 Week Range

Now: $14.50
Low: $3.97
High: $23.97

Volume

2,150,898 shs

Average Volume

1,234,803 shs

Market Capitalization

$1.34 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.76